Isracann Biosciences Inc. (OTCPK:ISCNF) (CSE:IPOT) (XFRA:A2PT0E) a multi-faceted organization with a natural health medicine division (Praesidio Health) in Canada and holdings in Israel, has signed a distribution agreement for Praesidio Health products with
Praesidio Health, a wholly-owned subsidiary of Isracann Biosciences Inc. (OTCPK:ISCNF) (CSE:IPOT) (XFRA:A2PT0E), has completed the natural product number (NPN) submissions to Health Canada for its first formulations.
Isracann Biosciences Inc. (OTCPK:ISCNF) (CSE:IPOT) (XFRA:A2PT0E) has closed its acquisition of Praesidio Health Inc. Pursuant to the definitive agreement dated March 24, 2022 with Praesidio and the shareholders of Praesidio, the company acquired all of the issued and outstanding shares in the capital of Praesidio for aggregate c
Former Crop One and Sensei Ag CEO Sonia Lo Joins Urban-Gro’s Board Of Directors
Urban-gro, Inc. (NASDAQ: UGRO) announced Thursday that Sonia Lo agreed to join the company’s board of directors.